MedTrace Logo

ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

NCT01534819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1090

Last updated 2026-04-14

No results posted yet for this study

Summary

The ANCHOR registry is a multi-center, post-market, non-interventional, non-randomized, prospective study.

Subjects must sign an ICF prior to obtaining any study specific information. Subjects are eligible to be consented up to 30 days post-procedure.

Enrolled subjects will be followed as per local 'standard of care' for up to 5 years post procedure. Study recommended follow-up is per SVS and ESVS guidance.

Conditions

  • Aortic Aneurysm

Interventions

DEVICE

EndoAnchor™

Use of the EndoAnchor™ in conjunction with endograft

PROCEDURE

endovascular treament

implantation of a device inserted through an artery

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Jean-Paul de Vries, MD · Universitair Medisch Centrum Groningen, Netherlands

  • William Jordan, MD · Augusta University Health, United States

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2020-11-12
Completion
2026-04-08

Countries

  • United States
  • Australia
  • Austria
  • France
  • Germany
  • Italy
  • Netherlands
  • New Zealand
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01534819 on ClinicalTrials.gov